1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BIOLOGICS CONTRACT DEVELOPMENT MARKET BY SOURCE
5.1. Introduction
5.2. Mammalian
5.3. Non-Mammalian
6. BIOLOGICS CONTRACT DEVELOPMENT MARKET BY SERVICE
6.1. Introduction
6.2. Upstream Processing
6.3. Downstream Processing
6.4. Others
7. BIOLOGICS CONTRACT DEVELOPMENT MARKET BY INDICATION
7.1. Introduction
7.2. Oncology
7.3. Immunological Disorders
7.4. Cardiovascular Disorders
7.5. Neurological Disorders
7.6. Others
8. BIOLOGICS CONTRACT DEVELOPMENT MARKET BY APPLICATION
8.1. Introduction
8.2. Vaccines
8.3. Gene Therapies
8.4. Monoclonal Antibodies
8.5. Others
9. BIOLOGICS CONTRACT DEVELOPMENT MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. WuXi Biologics (WuXi AppTec Co., Ltd)
11.2. Abzena
11.3. FUJIFILM Biotechnologies
11.4. KBI Biopharma Inc.
11.5. AGC Biologics
11.6. Thermo Fisher Scientific Inc.
11.7. Curia Global, Inc.
11.8. Bionova Scientific LLC (Asahi Kasei)
11.9. Boehringer Ingelheim
11.10. Mabion SA
11.11. Lonza Group
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES